Tuesday, February 5, 2013

AAPL: Apple Is Dirt Cheap And Should Be Bought

Apple Is Dirt Cheap And Should Be Bought
by Larry Smith

Let me start with a confession, I do not own any Apple (AAPL) products, not even an iPod. I have family members who have iPods and iPhones, but I do not, so I think it is fair to say I am not a fan boy. I am a stock investor and I would like to think I look at stocks as investment instruments and no more. In the past, I had no interest in AAPL, it was a high-flying growth stock and it did not pay a dividend, which is not my cup of tea. I am a dividend growth investor looking for reasonably priced stocks that pay a nice growing dividend. Until recently, AAPL did not pay a dividend so I had no interest, although I did realize some investors were making a great deal of money on their AAPL investment. read more »

More on AAPL

Sell Apple And Buy...What Exactly? by Nick Butcher

Apple: New Analysis Offers Reasons For A Rally by Craig Van Pelt

Apple's Bright Spot In China - Not Really That Bright by Sarfaraz A. Khan

Other articles that mention AAPL

Why Secret Product Announcements Hurt Tech Stocks by Ian Wyatt

Nvidia's Apple Win May Disrupt Traditional Seasonality by Ashraf Eassa

BlackBerry Blows It With BlackBerry 10 Product Launch by Saibus Research


Why are you receiving this? You subscribed to real-time article alerts at Seeking Alpha.
If this email was forwarded to you and you wish to subscribe to this email, click here.

Manage your emails:
Get alerts on additional tickers and manage all your email alert choices here
I'm getting too many emails: manage your email alert choices
I'm no longer following AAPL: unsubscribe from all AAPL email alerts
This type of alert isn't helpful to me: unsubscribe from article alerts on AAPL

To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.

Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001

50 Jaw-Dropping Pharmaceutical, Biotech, and Life Science Statistics

The Motley Fool
My Fool Daily
FEBRUARY 5, 2013
HEADLINE OF THE DAY
50 Jaw-Dropping Pharmaceutical, Biotech, and Life Science Statistics
The pharmaceutical, biotech, and life science sector can be intimidating for those without a background in science. To help, here are some facts to get you started.
Click here to read more.
TODAY'S WATCHLIST ARTICLES

9 Dividend Stocks to Buy Today
A top Motley Fool analyst has identified 9 rock-solid dividend stocks he believes will both trounce the market and hand you better-than-Treasury yields for years to come. It includes 5 "dividend rock stars" including a major oil giant, 2 "high-yielding dividend divas" including a New York City bank yielding nearly 8%, and 2 "dividend up-and-comers" featuring a little-known investment bank and a distributor of medical and surgical equipment. Today you can read through this report -- and get all the companies' names and ticker symbols -- completely FREE. Simply click here to get started!

EDITOR'S PICKS
Motley Fool Market Foolery
LISTEN NOW
Dell's Private Party
Meet Oil Refiners' New Best Friend: Warren Buffett
By Tyler Crowe
Here's Why the Media Is Wrong About Bank of America
By John Maxfield
Is Profit No Longer the Motive of Business?
By Travis Hoium
For all the news on the companies you care about, click over to www.MyWatchlist.com.
Brought to you by The Motley Fool / fool.com / Follow us: Facebook icon  Twitter icon
This is a message from The Motley Fool · 2000 Duke St. · Alexandria, VA 22314
Legal Information · Copyright ©1995-2013 The Motley Fool. All rights reserved.

If you no longer wish to receive this email, please unsubscribe now.
You may also add, change, or remove any other Motley Fool email subscription.